The Elecsys ApoE4 test eliminates the need for confirmatory genetic testing in the significant proportion of Alzheimer’s patients who do not carry the ApoE4 variant
Using just a few drops of blood from a finger prick, the test can help guide treatment decisions in 15 minutes – reducing unnecessary antibiotic use, detecting bacterial infections that may otherwise be missed, and ultimately improving patient outcomes
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ transplant recipients
The board is comprised of leading experts in cell-free DNA, oncology screening, and molecular diagnostics across research, development, and commercialization
Dr. Rinck emphasized the importance of reliable framework conditions, consistent industry standards, and open dialogue
Bioxytran’s drug candidate, PHM23, utilizes a novel mechanism of action that targets galectin proteins critical to viral replication
Integration of HiFi long-read whole-genome sequencing expands the collective capabilities of iHope’s global rare disease network
The aim of this project is to serve as a model case for AI adoption in public and general hospitals nationwide
In sepsis, the delay of even one hour in diagnosis can mean the difference between life and death. What if a standard blood test powered by AI, could flag the risk before symptoms even appear?
Proprietary multianalyte and multiomic assay with optimized machine learning capabilities achieve significantly higher 82% sensitivity and 97% specificity in high-risk populations
Find out how Streck is adapting to evolving clinical lab needs by providing quality controls for automated molecular diagnostics
iFAST ONE reduces antimicrobial susceptibility test time to under 3 hours
As an ambassador for the Women in STEM Network, Dr. Vasiliki E. Kalodimou is mentoring future scientists and redefining what is possible for women
New research and clinical evidence are redefining how clinicians detect and manage preeclampsia, with angiogenic biomarker testing offering earlier, clearer insight into maternal risk
Leading experts reveal how laboratory biomarkers are transforming emergency and long-term cardiac care around the world
This partnership aims to enable faster, more reliable respiratory testing outside traditional lab settings without the need for instruments or extended sample preparation
First U.S. commercial agreement delivers next-generation technology for faster, more accurate diagnostics
Dr. Nathan Ledeboer highlights how new antimicrobial combos and accurate susceptibility testing are helping fight against AMR
Siemens Healthineers supported the health and science department and the local organizing committee medical teams at three major global events in 2025, providing blood point-of-care testing and diagnostic imaging
One lab shares its experience boosting efficiency and accuracy with StatLab’s PiSmart Cassette and Slide printers
Agreement with Illumina brings industry-leading sequencing platforms together with Devyser’s validated genetic testing solutions
In this guest editorial, Dr. Wubin Qu, CSO and Co-Founder of iGeneTech, offers perspective on changing NGS workflows vs changing capture kit reagents
Reimagining clinical microbiology with key technologies and long-acting therapies
